Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer’s disease DOI Creative Commons
Yodai Kobayashi, Hirosuke Sugahara,

Kousuke Shimada

и другие.

Scientific Reports, Год журнала: 2017, Номер 7(1)

Опубликована: Окт. 12, 2017

It has previously been shown that the consumption of probiotics may have beneficial effects not only on peripheral tissues but also central nervous system and behavior via microbiota-gut-brain axis, raising possibility treatment with could be an effective therapeutic strategy for managing neurodegenerative disorders. In this study, we investigated oral administration Bifidobacterium breve strain A1 (B. A1) physiological processes in Alzheimer's disease (AD) model mice. We found B. to AD mice reversed impairment alternation a Y maze test reduced latency time passive avoidance test, indicating it prevented cognitive dysfunction. demonstrated non-viable components bacterium or its metabolite acetate partially ameliorated decline observed Gene profiling analysis revealed suppressed hippocampal expressions inflammation immune-reactive genes are induced by amyloid-β. Together, these findings suggest potential preventing AD.

Язык: Английский

Gut Microbiotas and Host Evolution: Scaling Up Symbiosis DOI
Michal Shapira

Trends in Ecology & Evolution, Год журнала: 2016, Номер 31(7), С. 539 - 549

Опубликована: Март 31, 2016

Язык: Английский

Процитировано

379

The role of the microbiome for human health: from basic science to clinical applications DOI Creative Commons
M. Hasan Mohajeri, Robert J. Brummer, Robert A. Rastall

и другие.

European Journal of Nutrition, Год журнала: 2018, Номер 57(S1), С. 1 - 14

Опубликована: Май 1, 2018

The 2017 annual symposium organized by the University Medical Center Groningen in Netherlands focused on role of gut microbiome human health and disease. Experts from academia industry examined interactions prebiotics, probiotics, or vitamins with disease, development early-life gut-brain axis. microbiota changes dramatically during pregnancy intrinsic factors (such as stress), addition to extrinsic diet, drugs) influence composition activity throughout life. Microbial metabolites, e.g. short-chain fatty acids affect signaling immune response. has a regulatory anxiety, mood, cognition pain which is exerted via Ingestion prebiotics probiotics been used treat range conditions including constipation, allergic reactions infections infancy, IBS. Fecal transplantation (FMT) highly effective for treating recurrent Clostridium difficile infections. affects virtually all aspects health, but degree scientific evidence, models technologies understanding mechanisms action vary considerably one benefit area other. For clinical practice be broadly accepted, mode action, therapeutic window, potential side effects need thoroughly investigated. This calls further coordinated state-of-the art research better understand document microbiome's health.

Язык: Английский

Процитировано

379

Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s Disease DOI
Meng‐Fei Sun, Yan‐Qin Shen

Ageing Research Reviews, Год журнала: 2018, Номер 45, С. 53 - 61

Опубликована: Апрель 26, 2018

Язык: Английский

Процитировано

344

Gut Microbiota and Dysbiosis in Alzheimer’s Disease: Implications for Pathogenesis and Treatment DOI Creative Commons
Shan Liu,

Jiguo Gao,

Mingqin Zhu

и другие.

Molecular Neurobiology, Год журнала: 2020, Номер 57(12), С. 5026 - 5043

Опубликована: Авг. 22, 2020

Understanding how gut flora influences gut-brain communications has been the subject of significant research over past decade. The broadening term "microbiota-gut-brain axis" from "gut-brain underscores a bidirectional communication system between and brain. microbiota-gut-brain axis involves metabolic, endocrine, neural, immune pathways which are crucial for maintenance brain homeostasis. Alterations in composition microbiota associated with multiple neuropsychiatric disorders. Although causal relationship dysbiosis neural dysfunction remains elusive, emerging evidence indicates that may promote amyloid-beta aggregation, neuroinflammation, oxidative stress, insulin resistance pathogenesis Alzheimer's disease (AD). Illustration mechanisms underlying regulation by pave way developing novel therapeutic strategies AD. In this narrative review, we provide an overview their dysregulation Novel insights into modification as preventive or approach AD highlighted.

Язык: Английский

Процитировано

333

Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer’s disease DOI Creative Commons
Yodai Kobayashi, Hirosuke Sugahara,

Kousuke Shimada

и другие.

Scientific Reports, Год журнала: 2017, Номер 7(1)

Опубликована: Окт. 12, 2017

It has previously been shown that the consumption of probiotics may have beneficial effects not only on peripheral tissues but also central nervous system and behavior via microbiota-gut-brain axis, raising possibility treatment with could be an effective therapeutic strategy for managing neurodegenerative disorders. In this study, we investigated oral administration Bifidobacterium breve strain A1 (B. A1) physiological processes in Alzheimer's disease (AD) model mice. We found B. to AD mice reversed impairment alternation a Y maze test reduced latency time passive avoidance test, indicating it prevented cognitive dysfunction. demonstrated non-viable components bacterium or its metabolite acetate partially ameliorated decline observed Gene profiling analysis revealed suppressed hippocampal expressions inflammation immune-reactive genes are induced by amyloid-β. Together, these findings suggest potential preventing AD.

Язык: Английский

Процитировано

329